HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Symptom severity, amount of treatment, and 1-year outcomes among dual diagnosis patients.

Abstract
This study reports on associations among symptom severity, amount of treatment, and 1-year outcomes in a national sample of 8,622 dual diagnosis patients, who were classified at treatment entry into low-, moderate-, and high-severity groups. Patients with more severe symptoms at intake had poorer 1-year outcomes. Higher severity patients did not receive adequate "doses" of care: Compared with low-severity patients, they had a shorter duration of care, although a longer duration was associated with improved outcomes; they also were less likely to receive outpatient substance abuse treatment, although more intensive treatment was associated with better drug outcomes. High-severity patients improved more on drug and legal outcomes, but less on psychiatric and family/social outcomes, than low-severity patients did when treatment was of longer duration or higher intensity. Dual diagnosis patients with highly severe symptoms would likely benefit from a longer episode of care that includes substance abuse and psychiatric outpatient treatment.
AuthorsChristine Timko, Rudolf H Moos
JournalAdministration and policy in mental health (Adm Policy Ment Health) Vol. 30 Issue 1 Pg. 35-54 (Sep 2002) ISSN: 0894-587X [Print] United States
PMID12546255 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Topics
  • Analysis of Variance
  • Diagnosis, Dual (Psychiatry)
  • Female
  • Humans
  • Interview, Psychological
  • Male
  • Mental Disorders (classification, diagnosis, rehabilitation)
  • Middle Aged
  • Severity of Illness Index
  • Substance-Related Disorders (classification, diagnosis, rehabilitation)
  • Treatment Outcome
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: